SupplyScape aims to provide electronic pedigree solutions to enable the pharmaceutical industry to secure their supply chains and to comply with regulations to limit drug counterfeiting. On August 23, 2009, SupplyScape was acquired by TraceLink. The terms of the transaction were not disclosed.
Latest SupplyScape News
Nov 4, 2020
TraceLink has acquired SupplyScape, a provider of products and services to secure the supply chain, and plans to improve its track and trace offering. SupplyScape provides services to help pharma companies with tasks including project design and development, implementation and performance optimisation. These services will now be provided as part of TraceLink, which is funded by FirstMark Capital. TraceLink believes that using this financial backing SupplyScape will be better equipped to serve its clients and further its ePedigree and RxAuthentication software. All TraceLink’s employees used to work at SupplyScape. Financial details of the deal have not been disclosed. Copyright - Unless otherwise stated all contents of this web site are © 2020 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
SupplyScape Frequently Asked Questions (FAQ)
When was SupplyScape founded?
SupplyScape was founded in 2003.
Where is SupplyScape's headquarters?
SupplyScape's headquarters is located at 500 Unicorn Park Drive, Woburn.
What is SupplyScape's latest funding round?
SupplyScape's latest funding round is Acquired.
How much did SupplyScape raise?
SupplyScape raised a total of $25M.
Who are the investors of SupplyScape?
Investors of SupplyScape include TraceLink, Flybridge Capital Partners, Pilot House Ventures, North Bridge Venture Partners, Pfizer Venture Investments and 3 more.
Who are SupplyScape's competitors?
Competitors of SupplyScape include TraceLink, InClinica, Acton Pharmaceuticals, ANI Pharmaceuticals, Combinent BioMedical Systems and 13 more.
Compare SupplyScape to Competitors
AkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.
Century Pharmaceuticals is a generic drug manufacturer based in India.
Intarcia Therapeutics operates as a biopharmaceutical company. The company develops and commercializes therapies to transform the prevention and management of chronic diseases. The company was founded in 1995 and is based in Boston, Massachusetts.
Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.
GeneraMedix Inc. is a pharmaceutical company that develops, markets and distributes generic injectable products. nnThe company's MissionnnThe company aims to bring to market generic products where the active pharmaceutical ingredient is difficult to source, manufacturing or regulatory hurdles exist and are difficult to overcome, or where product is in short supply. n
Embera NeuroTherapeutics is a clinical stage pharmaceutical company developing treatments for to potentially treat a range of addictions located in the greater Boston, MA area.